INSMED INC Increase (Decrease) in Other Noncurrent Assets
INSMED INC (INSM) reported Increase (Decrease) in Other Noncurrent Assets of $7.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- INSMED INC increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $5.23M.
- INSMED INC increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $2.36M.
- INSMED INC increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $11.79M.
- INSMED INC increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $2.85M, a 71.70% decline year-over-year.
- INSMED INC increase (decrease) in other noncurrent assets for fiscal 2025 was $2.12M.
- INSMED INC increase (decrease) in other noncurrent assets for fiscal 2024 was -$8.34M, a 141.52% decline from fiscal 2023.
- INSMED INC increase (decrease) in other noncurrent assets for fiscal 2023 was $20.07M, a 20.48% decline from fiscal 2022.
- INSMED INC increase (decrease) in other noncurrent assets for fiscal 2022 was $25.24M, a 3.31% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.59M 10-Q · filed 2026-08-06 | $19.37M derived: sum of 3 quarters · filed 2026-08-06 | $22.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.36M 10-Q · filed 2026-05-07 | $14.14M derived: sum of 2 quarters · filed 2026-05-07 | $17.00M derived: sum of 3 quarters · filed 2026-05-07 | $14.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $11.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $14.64M derived: sum of 2 quarters · filed 2026-02-19 | $12.29M derived: sum of 3 quarters · filed 2026-08-06 | $2.12M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $504.00K derived: sum of 2 quarters · filed 2026-08-06 | -$9.66M 10-Q · filed 2025-10-30 | -$12.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$12.52M 10-Q · filed 2026-08-06 | -$15.22M derived: sum of 3 quarters · filed 2026-08-06 | -$5.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$10.17M 10-Q · filed 2026-05-07 | -$12.88M derived: sum of 2 quarters · filed 2026-05-07 | -$2.80M derived: sum of 3 quarters · filed 2026-05-07 | -$18.17M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.36M derived: sum of 2 quarters · filed 2026-02-19 | -$8.00M derived: sum of 3 quarters · filed 2026-02-19 | -$8.34M 10-K · filed 2026-02-19 |
| 2024-09-30 | $10.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$5.29M derived: sum of 2 quarters · filed 2025-10-30 | -$5.63M 10-Q · filed 2025-10-30 | -$2.46M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$15.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$15.70M 10-Q · filed 2025-08-07 | -$12.53M derived: sum of 3 quarters · filed 2026-02-19 | -$3.08M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$333.00K 10-Q · filed 2025-05-08 | $2.84M derived: sum of 2 quarters · filed 2026-02-19 | $12.28M derived: sum of 3 quarters · filed 2026-02-19 | $14.51M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $12.62M derived: sum of 2 quarters · filed 2026-02-19 | $14.84M derived: sum of 3 quarters · filed 2026-02-19 | $20.07M 10-K · filed 2026-02-19 |
| 2023-09-30 | $9.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $11.67M derived: sum of 2 quarters · filed 2024-10-31 | $16.91M 10-Q · filed 2024-10-31 | $29.13M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.46M 10-Q · filed 2024-08-08 | $19.68M derived: sum of 3 quarters · filed 2025-02-20 | $17.17M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $5.23M 10-Q · filed 2024-05-09 | $17.45M derived: sum of 2 quarters · filed 2025-02-20 | $14.94M derived: sum of 3 quarters · filed 2025-02-20 | $24.18M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $12.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $9.71M derived: sum of 2 quarters · filed 2025-02-20 | $18.95M derived: sum of 3 quarters · filed 2025-02-20 | $25.24M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $6.73M derived: sum of 2 quarters · filed 2023-10-26 | $13.02M 10-Q · filed 2023-10-26 | $16.46M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $9.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $15.53M 10-Q · filed 2023-08-03 | $18.97M derived: sum of 3 quarters · filed 2024-02-22 | $17.34M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $6.29M 10-Q · filed 2023-05-04 | $9.73M derived: sum of 2 quarters · filed 2024-02-22 | $8.10M derived: sum of 3 quarters · filed 2024-02-22 | $10.99M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.81M derived: sum of 2 quarters · filed 2024-02-22 | $4.70M derived: sum of 3 quarters · filed 2024-02-22 | $24.43M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $1.26M derived: sum of 2 quarters · filed 2022-10-27 | $20.99M 10-Q · filed 2022-10-27 | $22.47M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $22.62M 10-Q · filed 2022-08-04 | $24.10M derived: sum of 3 quarters · filed 2023-02-23 | $25.63M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $19.73M 10-Q · filed 2022-05-05 | $21.21M derived: sum of 2 quarters · filed 2023-02-23 | $22.74M derived: sum of 3 quarters · filed 2023-02-23 | $24.42M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.01M derived: sum of 2 quarters · filed 2023-02-23 | $4.69M derived: sum of 3 quarters · filed 2023-02-23 | $6.26M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $3.22M derived: sum of 2 quarters · filed 2021-10-28 | $4.79M 10-Q · filed 2021-10-28 | $5.49M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.25M 10-Q · filed 2021-08-05 | $3.95M derived: sum of 3 quarters · filed 2022-02-17 | $7.17M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $1.57M 10-Q · filed 2021-05-06 | $2.27M derived: sum of 2 quarters · filed 2022-02-17 | $5.49M derived: sum of 3 quarters · filed 2022-02-17 | $10.53M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $703.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $3.92M derived: sum of 2 quarters · filed 2022-02-17 | $8.96M derived: sum of 3 quarters · filed 2022-02-17 | $16.01M 10-K · filed 2022-02-17 |
| 2019-09-30 | $3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $8.26M derived: sum of 2 quarters · filed 2020-10-29 | $15.30M 10-Q · filed 2020-10-29 | $15.30M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $12.09M 10-Q · filed 2020-08-06 | $12.09M derived: sum of 3 quarters · filed 2021-02-25 | $12.09M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $7.04M 10-Q · filed 2020-04-30 | $7.04M derived: sum of 2 quarters · filed 2021-02-25 | $7.04M derived: sum of 3 quarters · filed 2021-02-25 | $7.04M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |